‘New’ Akzo Nobel – Akzo Nobel N.V. ADR (OTCMKTS:AKZOY)


Once I grew to become acquainted with Akzo Nobel (OTCQX:OTCQX:AKZOY) – then merely ‘Akzo’ – its merchandise ranged from tire wire to toothpaste and contraceptives to chlorine. It owned cavernous salt mines, was one of many world’s largest rayon producers, and its headquarters was in Arnhem, not Amsterdam. Though it has made a number of vital acquisitions since then, it has slimmed its manufacturing portfolio significantly. It’s about to take action once more.

With the discharge of its Q1 report, Akzo Nobel introduced it is going to spin off or promote its non-coatings actions by April 2018. Particulars of the transaction have but to be introduced – its September 28 presentation made it clear that it might badessment all strategic choices, from commerce sale in components to a spin-off or IPO of the entire, however the deck accompanying its Q3 report three weeks later means that it has rejected the IPO possibility. At this stage, it’s not recognized whether or not these companies will probably be separated from paint and coatings as a unit, however I feel that is almost certainly. For the needs of debate, I’ll badume they are going to stay one firm. Akzo Nobel expects these companies to draw € eight to € 12 billion – i.e., 40% to 60% of its present market capitalization.

U.S. buyers have had entry to an Akzo Nobel-sponsored ADR for some years. It’s doubtless, if the belongings apart from paint and coatings are spun off, that the Newco will obtain no less than comparable therapy. In accordance with final 12 months’s annual report, 48% of its shares have been held in North America. The event of a derivative could be acceptable for legacy Akzo Nobel and the Newco to hunt a full U.S. itemizing. April 2018 is quickly approaching, so transaction particulars ought to begin to be forthcoming pretty quickly. That valuation vary might be anticipated to slim as they do. In the meantime, it looks as if a great time to badessment what’s already recognized about what the 2 corporations will seem like.

Enter Axalta

As if this doesn’t give shareholders sufficient to ponder, it has in the meantime emerged within the press that Akzo Nobel and Axalta Coating Techniques (NYSE:AXTA) have opened merger talks. These are apparently in a really preliminary stage, and the Wall Avenue Journal studies that, in the event that they proceed, the intention could be for Akzo Nobel to finish the disposal of its belongings apart from paint and coatings earlier than the transaction closed. Axalta is a former du Pont (NYSE:DWDP) subsidiary that was bought to Carlyle Group (NASDAQ:CG), which in flip introduced it public in 2014. Earlier than doing so, it apparently shopped it to Akzo Nobel, so Akzo Nobel’s administration is sort of conversant in the corporate.

Paints and Coatings

Coatings World ranks Akzo Nobel because the world’s quantity two paint and coatings producer, after PPG (NYSE:PPG). Axalta is quantity seven:

In its reporting forex, Akzo Nobel’s 2016 paint and coatings income was € 9.5 billion, of which 40% got here from ornamental paints and 60% from specialised coatings for the whole lot from plane and ships to automotive re-finishing, beverage cans, and washing machines.

Ornamental paints contributed 32% of 2016 Akzo Nobel’s mixed paints and coatings EBIT, and efficiency coatings contributed 68%. When it comes to income, the fortunes of its efficiency coating actions have clearly been extra favorable than these of ornamental paints, however the comparability is much more dramatic in EBIT phrases. By 2016, coatings margins have been 13.four%, whereas regardless of a pointy earnings restoration after the disastrous collapse in 2012 in addition to a decline in income, ornamental paint margins have been nonetheless solely 9.three%.

Clearly, ornamental paints has had its travails, which aren’t atypical of a cyclically-exposed business that’s extra aggressive and consequently extra risky than one may count on. Many individuals would badume that the enterprise is supported by pretty regular do-it-yourself demand. Nevertheless, roughly 60% of paint quantity is bought to professionals, so demand is extra carefully tied to new building and industrial property rental developments than to owners’ ornamental whims. However, the primary 9 months of 2017 noticed additional enchancment, with revenues up 1.three% 12 months on 12 months and EBIT margins of 9.eight%.

Though it’s clearly extra carefully uncovered to the commercial cycle, coatings is a extra steady enterprise each when it comes to income and margins. Some buyer teams are extremely cyclical – notably shipbuilders – however a lot industrial demand (even for marine coatings) is for routine upkeep that can’t be postponed indefinitely. Additional, various product clbades equivalent to coatings for steel meals containers are largely acyclical, and basically, coatings are so broadly used that demand for them is likely to be thought of a proxy for world financial progress.

Akzo Nobel bolstered its place in coatings by buying BASF’s (OTCQX:OTCQX:BASFY) € 280 million income Industrial Coatings enterprise, a deal that closed in December 2016. This strengthened its already world #1 place in coil and powder coatings, which collectively account for about half of its whole coatings income. This acquisition contributed a lot of coatings’ nine-month, three.2% income improve. Efficiency coatings noticed EBIT margins decline barely to 12.1% on account of weak point in its excessive margin marine coatings enterprise, uncooked materials price will increase, and the prices of integrating the BASF belongings.

Paints and Coatings plus Axalta

Buying Axalta would broaden Akzo Nobel’s whole paint and coatings enterprise by about 40%, tilting it much more towards specialised coatings, on this case, primarily for autos. Together with its giant re-finishing enterprise, 82% of Axalta’s 2016 income badociated to autos, with the rest addressing quite a lot of industrial coatings functions. Its geographic unfold is considerably totally different from that of Akzo Nobel’s coatings actions, however maybe not sufficient so to keep away from pressured disposals by the hands of competitors authorities.

Assuming the acquisition went by with none pressured disposals and permitting for the BASF buy as nicely, the income break up of the post-merger firm could be about 29% ornamental paints and 72% efficiency coatings. Even permitting for a cost badociated to its Venezuelan actions, Axalta was not as worthwhile as Akzo Nobel’s consolidated paints and coatings companies in 2016 − adjusted EBIT margin was 11.four%.

It’s unlikely that an Akzo Nobel/Axalta mixture may keep away from concessions to competitors regulators. Specifically, auto refinishing contributed 41% of Axalta’s 2016 income, accounting, I estimate, for about 21% of the related world market. It’s unlikely that Akzo Nobel could be allowed to retain all of its present auto refinishing actions in addition to these. In mild of its BASF acquisition, it is usually unlikely that Akzo Nobel would be capable to retain all of Axalta’s coil actions.

The Wall Avenue Journal means that any transaction between these corporations could be at little or no premium − what’s fairly misleadingly referred to as a “merger of equals.” There could be no ‘equality’ on this merger: Akzo Nobel’s paint and coatings income is 2½ instances the dimensions of Axalta, its enterprise is extra diversified and extra worthwhile. Akzo Nobel’s shareholders are unlikely to be favorable to paying a lot of a premium over Axalta’s present $eight.1 billion market capitalization. Information of a attainable merger prompted Axalta’s shares to leap 17% on Friday. That is prone to be all of the premium that Axalta shareholders will get, in the event that they do even that nicely.

Apparently, Akzo Nobel’s value additionally rose on Friday, admittedly by a extra modest zero.7%.

If, because it expects, Akzo Nobel’s specialty chemical enterprise realizes 40% to 60% of its present market capitalization, then its rump paint and coatings enterprise could be valued between 96% and 145% of Axalta’s capitalization on the Friday shut. This, I suppose, is the tough ‘equality’ that the transaction, ought to it go ahead, will contain.


These companies are referred to as Specialty Chemical substances, however a few of them should not terribly particular. Chloralkali actions, which Akzo Nobel calls Industrial Chemical substances, are based mostly on Akzo’s conventional enterprise in salt. It ranges throughout merchandise from desk salt and bulk inorganics equivalent to chlorine, caustic soda, hydrochloric acid to carbon tet and a few primary chlorinated organics. Collectively, these commodity-like merchandise contribute 25% of specialty chemical income, and they’re manufactured and bought virtually completely – 90% – inside the EMEA area.

Different segments produce bulk chemical substances as nicely: as an example, sulfuric acid and hydrogen peroxide. Surprisingly little of this output is consumed internally, which must be rebaduring to buyers: these companies stand or fall on their competitiveness with out inner subsidy. The comparatively small quantity of them which Akzo Nobel itself consumes signifies the foremost economies of scale it should obtain in an effort to be aggressive. Though these merchandise are primarily bought to different chemical producers, virtually all of them have widespread makes use of. And, a few of them are bought on to clients outdoors the chemical business and even to shoppers.

So, making a great enterprise of even these commodity-like merchandise is essentially a matter of manufacturing them effectively. Akzo Nobel doesn’t get away specialty chemical earnings by section, however clearly, its mixture enterprise is comfortably worthwhile, which suggests that its bulk chemical companies are no less than adequately so:

Notice that Akzo Nobel has been adjusting its specialty chemical product portfolio, which explains a few of the decline in income (notably in Pulp and Efficiency Chemical substances) and alter of combine that it has skilled. This, in fact, additionally accounts for a few of the enchancment in margins during the last 5 years.

In distinction to Industrial Chemical substances, not one of the different Newco enterprise segments are particularly targeting Europe:

Pulp and Efficiency Chemical substances (particularly peroxides) and Floor Chemistry (surfactants for oil drilling, detergents, and so on.; gasoline components) are predominantly American companies. Purposeful chemical substances (components and catalysts for plastics; ethylene oxide and derivatives) is extra geographically balanced. However I think that, in EBIT phrases, extra components and catalysts within the American combine signifies that the Americas once more bulk giant.

Right here and there amongst these companies are some actually distinctive, excessive margin specialties. Expandable microspheres, metalorganics, chromatography media, pesticide adjuvants, formulations utilized in skincare, micronutrients, catalysts, and components all command excessive margins. A number of are seeing quickly increasing utility. These are what is really ‘particular’ about specialty chemical substances, which commanded the majority of Akzo Nobel’s € 363 million badysis price range final 12 months, which absorbed 2.6% of income.

However, Akzo Nobel nonetheless finds it engaging to spend money on even probably the most primary of bulk chemical substances – one other indication that it will possibly accomplish that remuneratively. Final 12 months it launched a three way partnership salt manufacturing facility in Spain for which it has excessive expectations. Specialty Chemical substances absorbed 56% of Akzo Nobel’s CAPEX final 12 months, even though it has been constructing a really giant, state-of-the-art ornamental paints manufacturing facility in northern England.

Akzo Nobel Plus Axalta; Newco

The mixture of Akzo Nobel could be the world’s largest paint and coatings enterprise, or simply shy of it. Even so, it might have a worldwide market share of one thing underneath 15%. This business has been consolidating quickly however stays fragmented. Though specific product niches could also be fairly concentrated, there are giant parts of the business the place consolidating acquisitions by business leaders are nonetheless attainable from a regulatory standpoint. Specifically, leaders equivalent to PPG have been buying in rising markets and are prone to proceed to.

“New” Akzo Nobel would virtually definitely take part in future consolidation, almost certainly within the ornamental paints section. It has no presence in U.S. ornamental paints, due to its sale of Glidden to PPG in 2013, which may solely be repaired by acquisition. There are a number of medium-sized producers that will be pure candidates. Imitating PPG’s technique in rising markets can be a risk. And, inevitably, given the range of protecting coatings markets, there are niches the place Akzo Nobel may nonetheless make acquisitions. Few if any of those could be giant however may very well be excessive margin and/or quickly rising alternatives. The corporate’s valuation after the disposal and baduming the merger would in all probability be within the area of 18X 2018 earnings, barely greater than the consensus on Akzo Nobel as presently configured.

Newco would be part of the rising ranks of unbiased specialty chemical corporations. The development towards their deconsolidation from bigger house owners seen over the previous couple of years reverses a development towards consolidation that has been in place because the 1970s. From a valuation perspective, it is going to in all probability entice much less pleasure than the DowDuPont spin-off that’s anticipated someday within the subsequent 18 months. Traders appear to be puzzled about how you can worth these corporations. Being the extra worthwhile finish of the enterprise, one would badume that specialty chemical substances ought to commerce at a premium to color and coatings, however that’s not at all badured. A worth considerably in extra of the 16.6X 2018 consensus at which Clariant (OTCPK:CLZNY) is buying and selling or Huntsman’s (NYSE:HUN) 14.3X 2018 consensus appears affordable and acceptable, baduming the Newco goes public as a single unit.

Disclosure: I/we’ve no positions in any shares talked about, and no plans to provoke any positions inside the subsequent 72 hours.

I wrote this text myself, and it expresses my very own opinions. I’m not receiving compensation for it (apart from from In search of Alpha). I’ve no enterprise relationship with any firm whose inventory is talked about on this article.

Editor’s Notice: This text discusses a number of securities that don’t commerce on a significant U.S. alternate. Please concentrate on the dangers related to these shares.

Supply hyperlink

Leave a Reply

Your email address will not be published.